Results 241 to 250 of about 109,968 (264)

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul Parikh, Sagar Lonial
exaly  

Incidence and Risk Factors Associated with Infection after Chimeric Antigen Receptor T Cell Therapy for Relapsed/Refractory B-cell Malignancies

Cell Transplantation, 2021
Feng Zhu, Guoqing Wei, Wenjun Wu
exaly  

Leukemic extracellular vesicles induce chimeric antigen receptor T cell dysfunction in chronic lymphocytic leukemia

Molecular Therapy, 2021
Michelle J Cox, Fabrice Lucien, Reona Sakemura   +2 more
exaly  

Ciltacabtagene autoleucel, a B-cell maturation antigen-directed chimeric antigen receptor T-cell therapy in patients with relapsed or refractory multiple myeloma (CARTITUDE-1): a phase 1b/2 open-label study

Lancet, The, 2021
Deepu Madduri, Saad Z Usmani, Andrzej J Jakubowiak   +2 more
exaly  

Chimeric Antigen Receptor T-Cell Therapy–Associated Cardiomyopathy in Patients With Refractory or Relapsed Non-Hodgkin Lymphoma

Circulation, 2020
Sarju Ganatra, Robert A Redd, Salim Hayek   +2 more
exaly  

Incidence, clinical characteristics and prognosis of tumor lysis syndrome following B-cell maturation antigen-targeted chimeric antigen receptor-T cell therapy in relapsed/refractory multiple myeloma

Frontiers in Immunology, 2023
Cheng Zu, Yanlei Zhang, Lin-qin Wang
exaly  

Chimeric Antigen Receptor on T Cells

2008
Laurence J. N. Cooper, Sourindra N. Maiti   +1 more
openaire   +1 more source

Cutaneous manifestations of chimeric antigen receptor T-cell therapy: An introduction for dermatologists

Journal of the American Academy of Dermatology, 2022
Kelsey B Nusbaum Bs, Samantha M Jaglowski, Jennifer Nam Choi   +2 more
exaly  

Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy

OncoImmunology, 2020
Anja Feldmann, Ralf Bergmann, Stefanie Koristka   +2 more
exaly  

Side-effect management of chimeric antigen receptor (CAR) T-cell therapy

Annals of Oncology, 2021
exaly